4.8.9Segment

Ophthalmology & Vision Devices

Medical devices for cataract surgery, refractive correction, glaucoma treatment, and retinal care used by ophthalmologists and ophthalmic surgery centers.

5
Verticals

Overview

Ophthalmology & Vision Devices covers medical devices for cataract surgery, refractive correction, glaucoma treatment, and retinal care, used by ophthalmologists and ophthalmic surgery centers. The market is led by Alcon and Johnson & Johnson Vision, with intraocular lenses (IOLs), surgical equipment, and minimally invasive glaucoma surgery (MIGS) as key categories.

Demand is driven by the aging population and rising cataract and retinal procedure volumes, with premium IOLs a higher-value growth area. It is a consolidated, innovation-driven category combining capital equipment, implants, and consumables.

Market snapshot

Market size
~$6.5B
Growth
~1.1%CAGR (2017–22, nominal)
Companies
~450
FragmentationConsolidated

U.S. Census Bureau 2022 CBP/Economic Census, NAICS 339115 (Ophthalmic Goods Manufacturing) — includes broader ophthalmic goods.

Business model & economics

Revenue model
Implants, equipment, and consumables for eye care
Recurring revenue
Moderate — procedure-driven implants and consumables
EBITDA margin
18–28%
Capex intensity
High
  • Aging-driven cataract and retinal procedure growth.
  • Premium IOLs a higher-value growth area.
  • Led by Alcon and J&J Vision.

M&A deal context

Moderate deal activity

Who’s acquiring

Ophthalmic-device strategicsDiversified medtech platformsVC-backed innovators

What’s driving deals

  • Premium-IOL and MIGS innovation.
  • Aging-demographic procedure demand.
  • Acquisition of ophthalmic innovation.

Verticals in this segment

  • 4.8.9.1Dry Eye & Ocular Surface Treatment Devices

    Intense pulsed light (IPL) systems, thermal pulsation devices, and diagnostic tools for meibomian gland dysfunction and dry eye disease management.

  • 4.8.9.2Glaucoma Treatment Devices

    Micro-invasive glaucoma surgery (MIGS) implants, drainage tubes, laser treatment systems, and IOP monitoring devices for glaucoma management.

  • 4.8.9.3Intraocular Lenses (IOLs) & Cataract Platforms

    Premium and standard intraocular lenses, phacoemulsification systems, and cataract surgery platforms used in millions of annual procedures globally.

  • 4.8.9.4Laser Refractive & LASIK Systems

    Excimer laser platforms, femtosecond laser systems, and diagnostic devices used for LASIK, LASEK, SMILE, and other laser vision correction procedures.

  • 4.8.9.5Retinal & Vitreoretinal Devices

    Vitrectomy systems, retinal laser platforms, intravitreal injection equipment, and imaging devices used in posterior segment surgical and medical procedures.

Find Ophthalmology & Vision Devices acquisition targets

Search Acquisera’s index for companies classified under Ophthalmology & Vision Devices (4.8.9) and build a targeted deal pipeline.

Search companies